The Hyperlipidemia Drugs Market is witnessing steady growth owing to the increasing prevalence of cardiovascular diseases, rising incidences of obesity and diabetes, and growing awareness regarding cholesterol management. As hyperlipidemia remains one of the leading risk factors for heart attacks, strokes, and other cardiovascular complications, healthcare providers continue to emphasize early...